Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Immune modulation of atherosclerosis.

Keaney JF Jr.

Circulation. 2011 Nov 29;124(22):e559-60. doi: 10.1161/CIRCULATIONAHA.111.074096. Review. No abstract available.

2.

Artery tertiary lymphoid organs contribute to innate and adaptive immune responses in advanced mouse atherosclerosis.

Mohanta SK, Yin C, Peng L, Srikakulapu P, Bontha V, Hu D, Weih F, Weber C, Gerdes N, Habenicht AJ.

Circ Res. 2014 May 23;114(11):1772-87. doi: 10.1161/CIRCRESAHA.114.301137. Review.

3.

2011 Nobel Prize in Physiology or Medicine: Toll-like receptors, dendritic cells, and their roles in atherosclerosis.

Tedgui A, Owens AP 3rd, Mackman N.

Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):2767-8. doi: 10.1161/ATVBAHA.111.240432. No abstract available.

5.

HDL and immunomodulation: an emerging role of HDL against atherosclerosis.

Yu BL, Wang SH, Peng DQ, Zhao SP.

Immunol Cell Biol. 2010 Mar-Apr;88(3):285-90. doi: 10.1038/icb.2009.112. Epub 2010 Jan 12. Review.

PMID:
20065996
6.

Dendritic cells in atherosclerosis.

Cartland SP, Jessup W.

Curr Pharm Des. 2013;19(33):5883-90. Review.

PMID:
23438964
7.

The immune system and murine atherosclerosis.

Getz GS, Vanderlaan PA, Reardon CA.

Curr Drug Targets. 2007 Dec;8(12):1297-306. Review.

PMID:
18220706
8.

Leishmaniasis, contact hypersensitivity and graft-versus-host disease: understanding the role of dendritic cell subsets in balancing skin immunity and tolerance.

Kautz-Neu K, Meyer RG, Clausen BE, von Stebut E.

Exp Dermatol. 2010 Aug;19(8):760-71. doi: 10.1111/j.1600-0625.2010.01116.x.

9.

Multiple functional targets of the immunoregulatory activity of galectin-1: Control of immune cell trafficking, dendritic cell physiology, and T-cell fate.

Cooper D, Ilarregui JM, Pesoa SA, Croci DO, Perretti M, Rabinovich GA.

Methods Enzymol. 2010;480:199-244. doi: 10.1016/S0076-6879(10)80011-4. Review.

PMID:
20816212
10.

Heat shock proteins and immunity: application of hyperthermia for immunomodulation.

Torigoe T, Tamura Y, Sato N.

Int J Hyperthermia. 2009 Dec;25(8):610-6. doi: 10.3109/02656730903315831. Review.

PMID:
20021222
11.

Attenuation of early atherosclerotic lesions by immunotolerance with β2 glycoprotein I and the immunomodulatory effectors interleukin 2 and 10 in a murine model.

De Haro J, Esparza L, Bleda S, Varela C, Sanchez C, Acin F.

J Vasc Surg. 2015 Dec;62(6):1625-31. doi: 10.1016/j.jvs.2014.05.096. Epub 2014 Jul 17.

12.

Regulatory T cells and tolerogenic dendritic cells as critical immune modulators in atherogenesis.

Sasaki N, Yamashita T, Kasahara K, Takeda M, Hirata K.

Curr Pharm Des. 2015;21(9):1107-17. Review.

PMID:
25312730
13.

Kidney dendritic cells in acute and chronic renal disease.

Hochheiser K, Tittel A, Kurts C.

Int J Exp Pathol. 2011 Jun;92(3):193-201. doi: 10.1111/j.1365-2613.2010.00728.x. Epub 2010 Jul 30. Review.

14.

Immune mechanisms in atherosclerosis and potential for an atherosclerosis vaccine.

Chyu KY, Nilsson J, Shah PK.

Discov Med. 2011 May;11(60):403-12. Review.

15.

Protein modification for immune regulation.

Wu J.

J Mol Cell Biol. 2015 Dec;7(6):493. doi: 10.1093/jmcb/mjv067. No abstract available.

PMID:
26621966
16.

Chemokine receptor 7 knockout attenuates atherosclerotic plaque development.

Luchtefeld M, Grothusen C, Gagalick A, Jagavelu K, Schuett H, Tietge UJ, Pabst O, Grote K, Drexler H, Förster R, Schieffer B.

Circulation. 2010 Oct 19;122(16):1621-8. doi: 10.1161/CIRCULATIONAHA.110.956730. Epub 2010 Oct 4.

17.

Immunological responses to gut bacteria.

Green-Johnson JM.

J AOAC Int. 2012 Jan-Feb;95(1):35-49. Review.

PMID:
22468340
18.

Immunomodulation of atherosclerosis with a vaccine.

Shah PK, Chyu KY, Fredrikson GN, Nilsson J.

Nat Clin Pract Cardiovasc Med. 2005 Dec;2(12):639-46. Review.

PMID:
16306920
19.

Dendritic cells and regulatory T cells in atherosclerosis.

Cheong C, Choi JH.

Mol Cells. 2012 Oct;34(4):341-7. doi: 10.1007/s10059-012-0128-9. Epub 2012 Jun 28. Review.

20.

The expression and functions of toll-like receptors in atherosclerosis.

Cole JE, Georgiou E, Monaco C.

Mediators Inflamm. 2010;2010:393946. doi: 10.1155/2010/393946. Epub 2010 Jun 24. Review.

Supplemental Content

Support Center